Abhinav Singla, MD
Internal Medicine · Rochester, MNNPI 1104230002
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (53.9%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Otsuka America Pharmaceutical, Inc. at 54.3% of the total. Among internal medicine clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 39 payments — averaging $130.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$3K
- Merck$2K
- Novartis$101
- SK Life Science, Inc.$85
- GSK$65
- Biohaven Pharmaceuticals, Inc.$57
- plus $99 from 4 others
What the payments were for
- Consulting fees$1,75034%
- Speaking & faculty fees$2,75254%
- Food & beverage$59912%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 4 | $2,768 |
| Merck | 13 | $1,927 |
| Novartis | 6 | $101 |
| SK Life Science, Inc. | 3 | $85 |
| GSK | 4 | $65 |
| Biohaven Pharmaceuticals, Inc. | 3 | $57 |
| AstraZeneca | 3 | $55 |
| Bayer | 1 | $18 |
| Novo Nordisk | 1 | $14 |
| Impel Pharmaceuticals Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- REXULTI$2,752
How this compares
$5,101 in reported general payments places this provider in the 95th percentile of 1,924 internal medicine providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 13 | $347 |
| Rosuvastatin Calcium | 13 | $92 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Rochester
- Gregory PolandRochester$494K
- Ekta KapoorRochester$55K
- Luke SeaburgRochester$55K
- Robert PignoloRochester$52K
- Ilya ShadrinRochester$35K
- Brian JonesRochester$34K
- Jody OlsonRochester$26K
- James HaysRochester$23K
- Amit SoodRochester$22K
- Larissa Fujii-LauRochester$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.